Andrea De Censi
Champalimaud Foundation - Champalimaud Clinical Center · Ente Ospedaliero Ospedali Galliera · E.O. Ospedali Galliera
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrea De Censi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:51 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06982313 · Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast NeoplasmsEnte Ospedaliero Ospedali Galliera · completed · Breast Cancer Invasive · principal investigator
- N/ANCT06718647 · Efficacy and Tolerability of Low-Dose Enzalutamide in Prostate CancerMonica Boitano · not yet recruiting · Prostate Cancer Metastatic Disease · study chair
- Ph2/Ph3NCT06601205 · Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.Ente Ospedaliero Ospedali Galliera · completed · Prostate Cancer, Prostatic Intraepithelial Neoplasia · principal investigator
- Ph3NCT05725343 · A Prevention Trial of Canakinumab in Subjects at High Risk for Lung CancerMario Negri Institute for Pharmacological Research · terminated · Lung Cancer · principal investigator
- N/ANCT04932863 · BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active TreatmentEnte Ospedaliero Ospedali Galliera · completed · Neoplasms, Cancer, Treatment-Related · principal investigator
- Ph2NCT03047837 · A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc PatientsEnte Ospedaliero Ospedali Galliera · terminated · Tertiary Prevention in Colon Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.